Monarch Medical Technologies is a privately held medical technology company founded by clinicians with a vision of improving hospital-based glucose management. Providing the safest option on the market, Monarch is replacing traditional linear protocols with individualized and predictive computer-based solutions. With its flagship product, the EndoTool® Glucose Management System, the company pioneers the field of predictive therapeutic control technologies for managing drugs.
Monarch provides a degree of personalized care that results in lower readmission rates, reduced lengths of stay, reduced risk of hospital-acquired conditions & infections, and dramatically improved patient outcomes. Monarch’s technology is doing more than changing the conversation in over 220 hospitals throughout the United States — it’s helping providers achieve the coveted Triple Aim:
better health, better care, at a lower cost.
——————– Commitments ——————–
Patient Safety Movement
We are dedicated to the safety of patients receiving treatment on EndoTool and to the safety of caregivers providing the treatment. As a demonstration of this commitment, Monarch has joined the Patient Safety Movement and pledged “to make the physiological parameters displayed on [our] medical devices, subject to all applicable privacy laws, available to anyone or any entity that wants to use them to improve patient care and help reverse the tide of preventable patient deaths.”
American Diabetes Association
——————– Achievements ——————–
FDA Class II Medical Device
2006: EndoTool™ Glucose Management System receives FDA 510(k) Clearance as a Class II medical device.
2014: EndoTool IV™ receives FDA 510(k) Clearance as a Class II medical device.
2015: EndoTool SubQ™ receives FDA 510(k) Clearance as a Class II medical device.